A team of researchers from the Netherlands, the U.S. and the U.K. has found evidence that suggests tumor necrosis factor (TNF) cannot be used as a biomarker for rheumatoid arthritis (RA) treatment discontinuation. In their ...
Rapid, cheap and accurate tests continue to be essential for epidemiological surveillance and for health services to monitor and contain the spread of SARS-CoV-2. Brazilian scientists have contributed to endeavors in this ...
Nov 29, 2022
0
69
UniSA scientists have developed the world's first test to accurately predict mood disorders in people, based on the levels of a specific protein found in the brain.
Jan 19, 2021
0
298
Researchers at the Duke-NUS Medical School in Singapore have announced a new blood test for neutralizing antibodies against SARS-CoV2, the virus that causes COVID-19, and have formed public and private partnerships to begin ...
May 19, 2020
0
11
Researchers with the SFU Nanodevice Fabrication Group are developing a new biosensor that can be used to screen for Alzheimer's disease and other diseases. An overview of their work has been recently published in the journal ...
Jan 18, 2023
0
79
For even the most routine of medical checkups, a blood test is often the first order of business. But, for all its diagnostic power, this common test provides only a snapshot of the blood during a single moment in time.
Dec 22, 2020
0
60
Yu Lei, professor of chemical and biomolecular engineering, has invented a new platform that can perform high-sensitivity readings for a variety of disease biomarkers.
Jul 27, 2022
0
5
(HealthDay) -- Cxbladder, a derivative of the RNA assay uRNA, may be an effective alternative to cytology and nuclear matrix protein 22 (NMP22) assays for the detection of urothelial carcinoma, according to a study published ...
Aug 21, 2012
0
0
Researchers have developed and applied a robust, versatile antibody test to assist health authorities in managing the coronavirus disease 2019 (COVID-19) pandemic, according to a study published January 14 in the open-access ...
Jan 14, 2021
0
31
Researchers at Biolinker, a biotech startup based in São Paulo, Brazil, are developing a low-cost high-performance COVID-19 diagnostic test using only locally sourced inputs.
Jun 29, 2020
0
0
